NCT04863313View on ClinicalTrials.gov

Effect of a Probiotic on the Glycemic Profile and the Fecal Microbiota of Prediabetic Subjects (PREDIABETCARE)

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 11, 2021

Primary Completion Date

July 20, 2022

Study Completion Date

December 9, 2022

Conditions

PreDiabetesOverweight and Obesity

Interventions

DIETARY_SUPPLEMENT

Probiotic

Experimental group will consume one probiotic capsule every day during 12 weeks at breakfast.

DIETARY_SUPPLEMENT

Placebo

Placebo group will consume one placebo capsule every day during 12 weeks at breakfast.

Trial Locations (1)

31008

Center for Nutrition Research. University of Navarra, Pamplona

All Listed Sponsors

collaborator

GENBIOMA Aplicaciones SL

UNKNOWN

collaborator

Gobierno de Navarra/FEDER

UNKNOWN

lead

Clinica Universidad de Navarra, Universidad de Navarra

OTHER

NCT04863313 - Effect of a Probiotic on the Glycemic Profile and the Fecal Microbiota of Prediabetic Subjects (PREDIABETCARE) | Biotech Hunter | Biotech Hunter